Dayvigo Side Effects and Weight Gain: Trial Incidence Rates
Weight gain wasn't a distinct adverse event in Dayvigo trials; somnolence was most common, at 10% (5mg) to 22% (10mg). See full incidence data by dose.
3 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 3 of 3 clinical reviews.
Weight gain wasn't a distinct adverse event in Dayvigo trials; somnolence was most common, at 10% (5mg) to 22% (10mg). See full incidence data by dose.
A detailed clinical review of Dayvigo (lemborexant) side effects, including rare, serious, and potentially long-lasting adverse events drawn from key trials, FDA labeling, and post-market surveillance data.
Case reports link lemborexant to euphoria and laughter alongside rarer risks like complex sleep behaviors and hallucinations. See what the evidence shows.